Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3Sarcoma 2Gynecologic 2CNS 2Thoracic 1Lymphoid 1Head & Neck 1Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 10Lung Neoplasms 7Carcinoma, Non-Small-Cell Lung 4Urinary Bladder Neoplasms 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Kaposi 1Sarcoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Unknown Primary 1Kidney Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Chondrosarcoma 1Central Nervous System Neoplasms 1Carcinoma, Ovarian Epithelial 1AIDS-related Kaposi sarcoma 1

Interventions

Peripheral Blood Stem Cell Transplantation 2Etoposide 2tislelizumab 1sargramostim 1milademetan 1fludarabine phosphate 1etoposide phosphate 1aldesleukin 1Radiotherapy 1Nicotine 1Levofloxacin 1Ifosfamide 1Filgrastim 1Cyclophosphamide 1Carboplatin 1Busulfan 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Testicular Germ Cell Tumor × etoposide phosphate × Thoracic × Clear all
NCT00003657 2017-01-20

High-dose ICE With Amifostine

Dana-Farber Cancer Institute

Phase 2 Completed
24 enrolled
CNSGenitourinaryGynecologicHead & NeckSarcomaThoracic

AIDS-related Kaposi sarcoma, Testicular Germ Cell Tumor, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Unknown Primary, Ovarian Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡